- Zynerba is an orphan-focused, neuropsychiatric, biopharmaceutical company taking a different and exciting transdermal approach to cannabinoids.
- Zynerba Pharma hisse senedi fiyatı, bu sayfada NASDAQ ZYNE borsa verileri gösteriliyor. ... Zynerba Pharma içindeki en son hareketleri izleyin.
- Click to Follow ZynerbaPharma. Zynerba Pharma.
- Zynerba is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
- Find the latest Zynerba Pharmace (ZYNE) press releases from Webull to help you in your trading and investing ZYNE decisions.
- The Investor Relations website contains information about Harmony Biosciences's business for stockholders, potential investors, and financial analysts.Bulunamadı: zynerba
- Until 2014, the company was known as AllTranz, Inc. Zynerba Pharmaceuticals Inc. was founded in 2007 and is headquartered in Devon, Pennsylvania.
- Zynerba Pharmaceuticals stock news and ZYNE charts. Free real-time prices, trades, and chat.
- Company profile page for Zynerba Pharmaceuticals Inc including stock price, company news, executives, board members, and contact information.
- Headquarters: 80 W. Lancaster Avenue, Suite 300, Devon, PA 19333, United States | Founded: 2007 | Employees: 28 Website:https://www.zynerba.com/.